Possibility of Non-Immunosuppressive Immunophilin Ligands as Potential Therapeutic Agents for Parkinsons Disease
Journal:
Current Pharmaceutical Design
Volume:
10
Page:
669-677
Author(s):
K. Tanaka and N. Ogawa
Targeting Gene Therapy for Prostate Cancer
Journal:
Current Pharmaceutical Design
Volume:
10
Page:
531-555
Author(s):
N. J. Maitland, L. J. Stanbridge and V. Dussupt
Retinoid Related Molecules an Emerging Class of Apoptotic Agents with Promising Therapeutic Potential in Oncology: Pharmacological Activity and Mechanisms of Action
Journal:
Current Pharmaceutical Design
Volume:
10
Page:
433-448
Author(s):
Enrico Garattini, Maurizio Gianni and Mineko Terao
Apoptosis is a Critical Cellular Event in Cancer Chemoprevention and Chemotherapy by Selenium Compounds
Journal:
Current Cancer Drug Targets
Volume:
4
Page:
13-28
Author(s):
R. Sinha and K. El-Bayoumy
NSAIDs and Chemoprevention
Journal:
Current Cancer Drug Targets
Volume:
4
Page:
29-42
Author(s):
Chinthalapally V. Rao and Bandaru S. Reddy
Regulation of Radiation-Induced Apoptosis by Early Growth Response-1 Gene in Solid Tumors
Journal:
Current Cancer Drug Targets
Volume:
4
Page:
43-52
Author(s):
Mansoor M. Ahmed
Novel Targeting of Apoptosis Pathways for Prostate Cancer Therapy
Journal:
Current Cancer Drug Targets
Volume:
4
Page:
85-95
Author(s):
Jason B. Garrison and Natasha Kyprianou
Intravenous and Regional Paclitaxel Formulations
Journal:
Current Medicinal Chemistry
Volume:
11
Page:
397-402
Author(s):
Rajendra Pawar, Ariella Shikanov, Boris Vaisman and Abraham J. Domb
Subject Index to Volume 4
Journal:
Current Pharmaceutical Biotechnology
Volume:
5
Page:
129-133
Author(s):
Bentham Science Publishers
5-HT3 Receptors
Journal:
Current Drug Targets - CNS & Neurological Disorders
Volume:
3
Page:
27-37
Author(s):
Brenda Costall and Robert J Naylor